DHT Holdings director sells 29,796 common shares
DHT Holdings, Inc. director Jeremy Kramer reported a sale of 29,796 shares of common stock on August 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DHT Holdings, Inc. director Jeremy Kramer reported a sale of 29,796 shares of common stock on August 7, 2026. The shares were sold at a weighted average price of $18.65 per share, in multiple trades between $18.64 and $18.66. Following this transaction, Kramer directly holds 71,332 shares of DHT Holdings, Inc. common stock. The transaction was classified as a sale in the open market and was not marked as made under a Rule 10b5-1 trading plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 29,796 | $18.65 | $556K |
Footnotes (1)
- F1. This transaction was executed in multiple trades at prices ranging from $18.64 to $18.66 per share; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, DHT Holdings, Inc., or a security holder of DHT
Key Figures
Key Terms
weighted average sale price financial
open market or private transaction market
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did DHT (DHT) director Jeremy Kramer report in this Form 4?
Was Jeremy Kramer’s DHT (DHT) stock sale under a Rule 10b5-1 plan?
What type of transaction did DHT (DHT) director Jeremy Kramer execute?
AI-generated analysis. How Rhea-AI works. Not financial advice.